📣 VC round data is live. Check it out!

Amplifon Valuation Multiples

Discover Amplifon's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Lepu Medical Technology, Minimed Group, Medacta Group, iRhythm Holdings and more.

Amplifon Overview

About Amplifon

Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.


Founded

1950

HQ

Italy

Employees

15.1K

Financials (LTM)

Revenue: $3B
EBITDA: $637M

EV

$5B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Amplifon Financials

Amplifon reported last 12-month revenue of $3B and EBITDA of $637M.

In the same LTM period, Amplifon generated $2B in gross profit, $637M in EBITDA, and $122M in net income.

Revenue (LTM)


Amplifon P&L

In the most recent fiscal year, Amplifon reported revenue of $3B and EBITDA of $622M.

Amplifon is profitable as of last fiscal year, with gross margin of 53%, EBITDA margin of 22%, and net margin of 4%.

See analyst estimates for Amplifon
LTMLast FY202320242025202620272028
Revenue$3B$3B$3B$3B$3B
Gross Profit$2B$1B$1B$2B$1B
Gross Margin84%53%56%57%53%
EBITDA$637M$622M$607M$648M$589M
EBITDA Margin23%22%23%23%21%
EBIT Margin12%12%11%11%9%
Net Profit$122M$106M$181M$169M$106M
Net Margin4%4%7%6%4%
Net Debt-$1B---

Financial data powered by Morningstar, Inc.

Amplifon Stock Performance

Amplifon has current market cap of $3B, and enterprise value of $5B.

Market Cap Evolution


Amplifon's stock price is $12.70.

Amplifon share price increased by 1.0% in the last 30 days, and decreased by 44.8% in the last year.

Amplifon has an EPS (earnings per share) of $0.40.

See more trading valuation data for Amplifon
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5B$3B1.1%1.0%14.4%-44.8%$0.40

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Amplifon Valuation Multiples

Amplifon trades at 1.8x EV/Revenue multiple, and 8.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Amplifon

EV / Revenue (LTM)


Amplifon Financial Valuation Multiples

As of June 4, 2026, Amplifon has market cap of $3B and EV of $5B.

Amplifon has a P/E ratio of 27.7x.

LTMLast FY202320242025202620272028
EV/Revenue1.8x1.8x1.9x1.8x1.8x
EV/EBITDA8.0x8.2x8.4x7.9x8.6x
EV/EBIT15.4x15.5x17.5x17.3x21.4x
EV/Gross Profit2.2x3.4x3.4x3.2x3.4x
P/E27.7x31.7x18.7x19.9x31.7x
EV/FCF21.2x14.8x16.1x14.4x14.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Amplifon Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Amplifon Margins & Growth Rates

Amplifon grew revenue by 2% and EBITDA by 6% in the last fiscal year.

In the most recent fiscal year, Amplifon reported gross margin of 53%, EBITDA margin of 22%, and net margin of 4%.

See estimated margins and future growth rates for Amplifon

Amplifon Margins

Last FY202420252026202720282029
Gross Margin53%57%53%83%
EBITDA Margin22%23%21%23%
EBIT Margin12%11%9%12%
Net Margin4%6%4%5%
FCF Margin12%13%12%9%

Amplifon Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth2%7%(1%)2%
Gross Profit Growth58%7%(6%)58%
EBITDA Growth6%7%(9%)12%
EBIT Growth1%1%(19%)39%
Net Profit Growth34%(6%)(37%)34%
FCF Growth(26%)12%(3%)(26%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Amplifon Operational KPIs

Amplifon's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Amplifon's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Amplifon's Rule of X is 27% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Amplifon
LTMLast FY202320242025202620272028
Rule of 4033%25%---
Bessemer Rule of X48%27%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue0%0%--0%
Opex to Revenue-45%45%46%45%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Amplifon Competitors

Amplifon competitors include Lepu Medical Technology, Minimed Group, Medacta Group, iRhythm Holdings, ICU Medical, Merit Medical Systems, Integer Holdings, MGI Tech, Haemonetics and Envista Holdings.

Most Amplifon public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Lepu Medical Technology3.8x3.7x12.2x12.2x
Minimed Group1.3x1.1x32.3x10.3x
Medacta Group4.7x4.5x16.3x16.0x
iRhythm Holdings4.9x4.5x52.9x42.3x
ICU Medical1.9x2.0x10.6x10.5x
Merit Medical Systems2.6x2.5x10.4x10.2x
Integer Holdings2.4x2.4x11.0x11.3x
MGI Tech6.5x6.2x111.7x79.2x

This data is available for Pro users. Sign up to see all Amplifon competitors and their valuation data.

Start Free Trial

Acquisitions by Amplifon

Amplifon has acquired 5 companies to date.

Last acquisition by Amplifon was on March 15th 2026. Amplifon acquired GN Hearing for $3B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Amplifon

GN Hearing
SISH Tucson
Safe in Sound Hearing
Magicson
Description
GN Hearing is a Danish manufacturer of hearing aids.
SISH Tucson is an Arizona-based organization delivering hearing care services and products to clients worldwide.
Safe in Sound Hearing is a franchisee of Miracle-Ear that manages 23 retail locations across Arizona. The company delivers hearing aids, replacement parts, and accessory products tailored for individuals with hearing impairments. Operating under the Miracle-Ear trademark, Safe in Sound Hearing extends its hearing care services through these outlets in cities including Phoenix, Tucson, and Mesa.
Magicson is a provider of hearing tests, aids, and maintenance services. Stockholm-based, it offers online audiometry and custom fittings with financing options. The company emphasizes prevention through workplace screening programs. Magicson stocks devices from Phonak and Oticon. Founded in 2018, it operates clinics in Scandinavia.
HQ CountryDenmarkUnited StatesUnited StatesItaly
HQ City
Copenhagen
Tucson, AZ
Phoenix, AZ
Turin
Deal Date15 Mar 202629 Apr 202529 Apr 20259 Jan 2025
Valuation$3Bundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Amplifon acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Amplifon

When was Amplifon founded?Amplifon was founded in 1950.
Where is Amplifon headquartered?Amplifon is headquartered in Italy.
How many employees does Amplifon have?As of today, Amplifon has over 15K employees.
Who is the CEO of Amplifon?Amplifon's CEO is Enrico Vita.
Is Amplifon publicly listed?Yes, Amplifon is a public company listed on Borsa Italiana.
What is the stock symbol of Amplifon?Amplifon trades under AMP ticker.
When did Amplifon go public?Amplifon went public in 2001.
Who are competitors of Amplifon?Amplifon main competitors include Lepu Medical Technology, Minimed Group, Medacta Group, iRhythm Holdings, ICU Medical, Merit Medical Systems, Integer Holdings, MGI Tech, Haemonetics, Envista Holdings.
What is the current market cap of Amplifon?Amplifon's current market cap is $3B.
What is the current revenue of Amplifon?Amplifon's last 12 months revenue is $3B.
What is the current revenue growth of Amplifon?Amplifon revenue growth (NTM/LTM) is 10%.
What is the current EV/Revenue multiple of Amplifon?Current revenue multiple of Amplifon is 1.8x.
What is the current EBITDA of Amplifon?Amplifon's last 12 months EBITDA is $637M.
What is Amplifon's EBITDA margin?Amplifon's last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Amplifon?Current EBITDA multiple of Amplifon is 8.0x.
What is the current FCF of Amplifon?Amplifon's last 12 months FCF is $240M.
What is Amplifon's FCF margin?Amplifon's last 12 months FCF margin is 9%.
What is the current EV/FCF multiple of Amplifon?Current FCF multiple of Amplifon is 21.2x.
How many companies Amplifon has acquired to date?As of June 2026, Amplifon has acquired 5 companies.
What was the largest acquisition by Amplifon?$3B acquisition of GN Hearing on 15th March 2026 was the largest M&A Amplifon has done to date.
What companies Amplifon acquired?Amplifon acquired GN Hearing, Gaes, Magicson, SISH Tucson, and Safe in Sound Hearing.
In how many companies Amplifon has invested to date?Amplifon hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Amplifon

Lists including Amplifon

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial